AMAG PHARMACEUTICALS, INC. Insider Trading for March 2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AMAG PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in AMAG PHARMACEUTICALS, INC. for March 2016.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 02 2016 | AVM | AMAG PHARMACEUTICA ... | Krop Julie | SVP Clinical & Regu ... | Option Exercise | A | 25.18 | 22,500 | 566,550 | 22,500 | |
| Mar 02 2016 | AVM | AMAG PHARMACEUTICA ... | Krop Julie | SVP Clinical & Regu ... | Grant | A | 0.00 | 9,000 | 0 | 31,000 | 22 K to 31 K (+40.91 %) |
| Mar 02 2016 | AVM | AMAG PHARMACEUTICA ... | Vittiglio Joseph | SVP, General Counse ... | Option Exercise | A | 25.18 | 20,000 | 503,600 | 20,000 | |
| Mar 02 2016 | AVM | AMAG PHARMACEUTICA ... | Vittiglio Joseph | SVP, General Counse ... | Grant | A | 0.00 | 9,000 | 0 | 24,000 | 15 K to 24 K (+60.00 %) |
| Mar 01 2016 | AVM | AMAG PHARMACEUTICA ... | THOMAS FRANK E | President & COO | Option Exercise | A | 25.18 | 40,000 | 1,007,200 | 40,000 | |
| Mar 01 2016 | AVM | AMAG PHARMACEUTICA ... | THOMAS FRANK E | President & COO | Grant | A | 0.00 | 17,000 | 0 | 114,195 | 97.2 K to 114.2 K (+17.49 %) |
| Mar 01 2016 | AVM | AMAG PHARMACEUTICA ... | THOMAS FRANK E | President & COO | Payment of Exercise | F | 26.28 | 515 | 13,534 | 97,195 | 97.7 K to 97.2 K (-0.53 %) |
| Mar 01 2016 | AVM | AMAG PHARMACEUTICA ... | THOMAS FRANK E | President & COO | Payment of Exercise | F | 27.01 | 458 | 12,371 | 97,710 | 98.2 K to 97.7 K (-0.47 %) |
| Mar 01 2016 | AVM | AMAG PHARMACEUTICA ... | THOMAS FRANK E | President & COO | Payment of Exercise | F | 27.01 | 1,361 | 36,761 | 98,168 | 99.5 K to 98.2 K (-1.37 %) |
| Mar 01 2016 | AVM | AMAG PHARMACEUTICA ... | THOMAS FRANK E | President & COO | Payment of Exercise | F | 27.01 | 7,417 | 200,333 | 99,529 | 106.9 K to 99.5 K (-6.94 %) |
| Mar 01 2016 | AVM | AMAG PHARMACEUTICA ... | HEIDEN WILLIAM K | CEO | Option Exercise | A | 25.18 | 85,000 | 2,140,300 | 85,000 | |
| Mar 01 2016 | AVM | AMAG PHARMACEUTICA ... | HEIDEN WILLIAM K | CEO | Grant | A | 0.00 | 36,000 | 0 | 218,458 | 182.5 K to 218.5 K (+19.73 %) |
| Mar 01 2016 | AVM | AMAG PHARMACEUTICA ... | HEIDEN WILLIAM K | CEO | Payment of Exercise | F | 26.28 | 1,701 | 44,702 | 182,458 | 184.2 K to 182.5 K (-0.92 %) |
| Mar 01 2016 | AVM | AMAG PHARMACEUTICA ... | HEIDEN WILLIAM K | CEO | Payment of Exercise | F | 27.01 | 1,843 | 49,779 | 184,159 | 186 K to 184.2 K (-0.99 %) |
| Mar 01 2016 | AVM | AMAG PHARMACEUTICA ... | HEIDEN WILLIAM K | CEO | Payment of Exercise | F | 27.01 | 4,070 | 109,931 | 186,002 | 190.1 K to 186 K (-2.14 %) |
| Mar 01 2016 | AVM | AMAG PHARMACEUTICA ... | HEIDEN WILLIAM K | CEO | Payment of Exercise | F | 27.01 | 10,649 | 287,629 | 190,072 | 200.7 K to 190.1 K (-5.31 %) |